StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)

Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –

Elevance Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Elevance Health's price to sales ratio was 0.5× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.3× to 0.9×, with a median of 0.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×+0.1
2025Dec 31, 20250.4×−0.1
2024Dec 31, 20240.5×−0.2
2023Dec 29, 20230.7×−0.1
2022Dec 30, 20220.8×−0.0
2021Dec 31, 20210.8×+0.2
2020Dec 31, 20200.7×−0.1
2019Dec 31, 20190.8×+0.0
2018Dec 31, 20180.7×+0.1
2017Dec 29, 20170.7×+0.2
2016Dec 30, 20160.5×−0.0
2015Dec 31, 20150.5×−0.0
2014Dec 31, 20140.5×+0.0
2013Dec 31, 20130.4×+0.1
2012Dec 31, 20120.3×−0.1
2011Dec 30, 20110.4×+0.1
2010Dec 31, 20100.4×−0.1
2009Dec 31, 20090.4×–

More Elevance Health figures

See a number that looks wrong?